Respiratory syncytial virus (RSV) causes repeated infections thought to be due to an ineffective immune response. We examined the hypothesis that incomplete immunity may result, in part, from RSV-infected alveolar macrophage production of IL-10 which can interfere with the production of immunoregulatory cytokines. We also assessed whether RSV induced the expression of the 2',5' oligoadenylate (2-5A)-dependent RNase L, an endoribonuclease involved in the antiviral activities of interferons. Human alveolar macrophages were exposed to medium (uninfected control), RSV, LPS, and RSV + LPS then were assessed for expression of the cytokines TNF-alpha, IL-1 beta, IL-8, IL-10, as well as 2-5A-dependent RNase L. LPS up-regulated the expression of protein and mRNA for all cytokines. RSV stimulated the protein levels of TNF-alpha, did not alter IL-1 beta, and decreased IL-8. RSV markedly stimulated protein expression of IL-10 and 2-5A-dependent RNase L. RSV had minor effects on the steady state mRNA levels of TNF-alpha, IL-1 beta, and IL-8, yet potently induced IL-10. Cells costimulated with RSV + LPS demonstrated reduced protein and mRNA levels of TNF-alpha, IL-1 beta, IL-8 but synergistically increased IL-10 levels compared to RSV-or LPS-activated cells. Kinetic analysis indicated that RSV induced a delayed and sustained increase in IL-10 transcripts. Furthermore, RSV-infected alveolar macrophage supernatants suppressed IL-1 beta and IL-8 production by LPSstimulated alveolar macrophages as did recombinant
fant's and young children's lungs, has been estimated to cause approximately one million deaths per year (1, 2) . A formalininactivated vaccine for RSV proved deleterious (1) , while a subunit vaccine is still under evaluation (3) . Those results, coupled with the unusual propensity for RSV to cause repeated infections, suggests this virus may interfere with an effective immune response (1) (2) (3) (4) . An effective immune response requires antigen presentation and the ordered expression of cytokines to activate lymphocytes (5) . Alveolar macrophages are the major immune-effector cells resident in the airways, the site of RSV infection in vivo, and may serve as antigen-presenting cells for this virus. Both in vivo and in vitro studies demonstrate that alveolar macrophages serve as a target for RSV infection, coexpress viral proteins, HLA-DR molecules, and biologically active cell-associated IL-1 (6, 7) . Expression of these molecules by antigen-presenting cells serve as critical determinants to initiate an effective immune response (5) .
We hypothesized that RSV disrupts the orchestrated production of cytokines by human alveolar macrophages contributing to an ineffective immune response. We further examined whether RSV stimulated expression of the 2 ',5' oligoadenylate (2-SA) -dependent RNase L, an endoribonuclease induced by IEN with preference for UU and UA sequences in singlestranded RNA (8) . Such sequences are present in the 3' untranslated regions of most cytokine messenger RNAs. Alveolar macrophages produce TNF-a, IL-6, and GM-CSF after in vitro infection with RSV (9, 10) . Although RSV infection in vivo induces alveolar macrophage expression of cell-associated TNF-a and IL-1/3 (6, 7) , in vitro studies demonstrate this virus: (a) causes only a transient increase in TNF-a mRNA, which is substantially less than that induced by LPS (9) (b), does not stimulate expression of type 1 (a, /3) IFN by differentiated macrophages, and (c) increases the expression of an IL-1 inhibitor (1 1, 12) . Thus, RSV stimulates both stimulatory and inhibitory cytokines that may regulate an effective immune response.
IL-10, originally described as cytokine synthesis inhibitory factor (13) , can potently inhibit expression of cytokines by blood-derived monocytes (13) (14) (15) (16) . EBV, a DNA virus, has incorporated a homologue of the IL-10 gene thought critical to latent infection by this virus (17) . There is very little known about the effects of other viruses, particularly RNA viruses tropic for the lung, on IL-10 expression. The effects of RSV infection or LPS activation on human alveolar macrophage expression of IL-10 has not been described. LPS does stimulate alveolar macrophage expression of TNF-a and IL-1/3, which can induce IL-8 production by both macrophages and lung epithelial cells (18) . IL-8 is a specific, chemotactic agent for neutrophils (19) . IL-10 has the potential to suppress IL-8, as well as other early cytokines (13) (14) (15) (16) . Finally, IL-10 can promote a TH2 helper cell response thus inducing specific antibodies which are known to be rapidly induced after RSV infection (20) . Thus, IL-10 might have an important role in the pathogenic mechanisms regulating the lung immune response to RSV.
We examined alveolar macrophages exposed to medium (uninfected controls), RSV, LPS (as a maximal stimulus to cytokine expression), and the combination of RSV + LPS on the expression of selected stimulatory and inhibitory cytokines. We specifically focused on the primary cytokines TNF-a and IL-1,/, both of which induce expression of IL-8 (18, 19) . We also examined IL-10 which can inhibit the expression of all of these cytokines (14) (15) (16) . The purpose of these studies was to determine if RSV altered the basal or LPS-stimulated cytokine expression by alveolar macrophages to provide possible insights into the immune response to RSV. Finally, TNF-a and IFN-/3 can inhibit RSV replication in lung cells through an undefined mechanism (21, 22) . We therefore examined the effects of RSV on the 2-5A-dependent RNase L which has the capacity to degrade viral and cytokine transcripts. The results of these studies are reported herein.
Methods
Donors. 20 healthy adult donors without a history of respiratory tract symptoms or use of medications or tobacco within the preceding four weeks underwent bronchoscopy and bronchoalveolar lavage after informed consent under a protocol approved by the Institutional Review Board of University Hospitals of Case Western Reserve University. Procedures for bronchoalveolar lavage were identical to those described previously (9, 21, 23) . Alveolar macrophages were isolated by adherence to plastic for 1 h in the presence of RPMI 1640 containing 10% (vol/vol) FBS (Hyclone, Logan, UT), 100 U/ml penicillin, 100 ig/ ml streptomycin, and 0.25 pg/ml amphotericin B (all supplements from Sigma Chemical Co., St. Louis, MO) (culture media). Adherent cells were > 95% viable as determined by acridine orange and ethidium bromide staining (21, 23) . Greater than 97% of these cells expressed the macrophage-specific CD 68 antigen (Dako Corp., Carpinteria, CA) as determined by indirect immunofluorescent staining using methods previously described (7) .
RSVpreparation. RSV strain A2 was obtained from Robert Chanock, National Institutes of Health, Bethesda, MD. Virus was propagated as previously described (21) (22) (23) in CV-1 cells (CCl no. 70; American Type Culture Collection, Rockville, MD). Virus stocks were prepared from CV-1 monolayers harvested at 48 h after infection. Harvested cells were sonicated on ice two times (Artek Sonic Dismembrator; Fisher Scientific, Pittsburgh, PA), then made 100 mM in MgSO4, 1.6 mM Hepes, 5 mM NaCl, centrifuged at 200 g to remove cellular debris, and frozen at -70°C. Titer of viral stocks were determined using methods previously described (21) (22) (23) . Virus stocks contained undetectable levels of TNF-a, IL-1,3, and IL-I 0. IL-8 levels were < 100 ng/ml while IL-6 levels were 320±40 pg/ml (mean±SD, n = 3 separate determinations) using assays described below.
Cell culture conditions. Alveolar macrophages at 106 cells/ml were exposed to culture media, Northern blot analysis was performed using methods previously described (9, 23, 27 
Results
Alveolar macrophage supernatant cytokine levels. The accumulation of TNF-a, IL-1/3, IL-8, and IL-10 in aliquots of supernatants from alveolar macrophages exposed to medium (uninfected controls), RSV (3 pfu/cell, a dose shown previously to maximally induce TNF-a, 9), LPS (10 pg/ml), and RSV + LPS (same doses) were examined. Results are shown in Fig.  1 . Alveolar macrophages incubated in medium alone (control, C) for 24 h yielded low supernatant levels of TNF-a, IL-13, and IL-10 while constitutive levels of IL-8 were comparable to previous studies (25, 26, 29, 30) . Alveolar macrophages infected with RSV for 2 h (R), then washed and cultured in fresh medium for 22 h, had increased supernatant levels of TNF-a and IL-10 compared to controls. In contrast, RSV infection did not alter IL-1/3 levels and actually suppressed To assess if these effects were mediated by infectious RSV, ultraviolet light-inactivated RSV (same dose as above prepared as previously described, 21 ) was added to alveolar macrophages for 2 h, replaced with fresh medium, and the supernatants were harvested after 22 h. TNF-a, IL-1,3, IL-8, and IL-10 levels were within ±+10% of the levels seen with cells exposed to control medium (n = 3). Furthermore, RSV stocks contained undetectable TNF-a, IL-1I3, IL-I0, and IL-8 levels of 100 ng/ml, less than constitutive levels produced by alveolar macrophages (Fig.  1) . RSV stocks did contain IL-6 at -320 pg/ml, and the effect of IL-6 on alveolar macrophage cytokine expression is assessed below.
Steady state mRNA levels of TNF-a, IL-I/3, IL-8, and IL-10. To assess whether RSV directly altered mRNA transcripts for these cytokines, Northern blot analyses were performed on total pooled RNA harvested at 24 h after stimulation from the first eight sequential donors whose supernatant cytokine results were shown in Fig. 1 . Northern blots were probed sequentially with 32P-cDNA probes for TNF-a, IL-1/3, IL-8, and the 18S form of ribosomal RNA, Fig. 2 A. Alveolar macrophages exposed for 24 h to medium alone (control, C) yielded undetectable steady state transcript levels of TNF-a, and low levels of IL-I/3 and IL-8. RSV (R) minimally increased the steady state mRNA levels of TNF-a, IL-1,6, and IL-8. RSV + LPS (R + L) yielded lower steady state transcript levels of TNF-a, IL-13, and IL-8 compared to cells exposed to RSV. Wells not loaded with RNA (blank, B) indicated the absence of nonspecific binding of 32P-labeled cDNA probes. LPS (L) markedly increased transcript levels for each of these cytokines and resulted in higher levels than cells exposed to RSV + LPS. Blots probed for expression of 18S ribosomal RNA indicated equivalent RNA loading.
In contrast, IL-10 expression by alveolar macrophages exposed to these stimuli for 24 h differed strikingly. IL-10 and GAPDH mRNA steady state levels analyzed by Northern blots are shown in Fig. 2 B (pooled RNA from the five donors whose IL-10 protein levels were shown in Fig. 1 ). Alveolar macrophages incubated in medium alone (control, C) had undetectable IL-10 while those exposed to RSV (R), LPS (L), and RSV + LPS (R + L) demonstrated increased IL-10 transcripts. (top). Reprobing this blot for GAPDH mRNA, as a constitutive housekeeping gene, demonstrated slightly lower GAPDH levels in LPS and RSV + LPS lanes (bottom).
Densitometry of TNF-a, IL-1,6, and IL-8 normalized to 18S rRNA as well as IL-10 normalized to GAPDH are shown in Fig. 2 C. RSV increased steady state levels of IL-8 and IL-10 compared to controls whereas LPS increased the levels of all cytokines. In contrast, RSV + LPS selectively stimulated IL-10 levels while yielding markedly reduced levels of TNF-a, IL-1,6, and IL-8 compared to LPS-stimulated cells alone. Thus RSV alone, or in combination with LPS, stimulated IL-10 mRNA levels.
Kinetics of expression of TNF-a, IL-8, IL-10, and HPRT. We have previously shown that RSV induces a rapid increase in TNF-a with a maximum increase at 2 h after viral exposure that returned to baseline by 8 h after viral exposure (9) . TNF natants was then determined by ELISA (Table II) . IL-1,8 levels from cells incubated with medium or those supplemented with uninfected alveolar macrophage supernatants (1:4, vol/vol) were higher than cells incubated with RSV-infected alveolar macrophage supernatants (1:4, vol/vol). Addition of a neutralizing antibody to IL-10 at the time of addition of RSVinfected supernatants completely reversed these effects (Table  II) . Addition of recombinant IL-10 (5 ng/ml) completely suppressed IL-1,/ accumulation which was again reversed by anti-IL-10. In addition, higher volumes of RSV-infected alveolar macrophage supernatants yielded increased inhibition (not shown). RSV-infected alveolar macrophage supernatants (1:4, vol/vol) also suppressed IL-8 accumulation by LPS-stimulated alveolar macrophages by 72±11% (mean+SD, n = 2), which again was completely reversed by anti-IL-10 (not shown). Thus, RSV stimulates IL-10 expression by alveolar macrophages that can inhibit early cytokine expression through an apparent autocrine mechanism.
RSV stocks did contain IL-6 at levels of 320±40 pg/ml which could potentially alter the levels of these cytokines. How- Table I body to IL-10 (Anti-IL-10) (500 neutralizing U/ml) as indicated. ND, not detectable within the sensitivity of the assay (24 pg/ml).
ever, addition of recombinant IL-6 at 450 pg/ml to alveolar macrophages stimulated with LPS had no detectable effects on IL-1/3 production whereas addition of 450 ng/mi inhibited by 84±13% (mean±SD, two separate donors). Because RSV-infected alveolar macrophages have been shown to produce IL-6
at levels of 10 ng/ 106 cells (10), we assessed IL-1I3 production in the presence of an mAb to IL-6 at levels sufficient to neutralize 75 ng/ml of IL-6 bioactivity. IL-13 production by RSV-infected or LPS-activated alveolar macrophages did not differ by > 18±11% from cells not exposed to anti-IL-6 (n = 2, separate donors). Thus, IL-10 appeared to primarily account for the suppression of IL-1 3 and IL-8 production by RSVinfected alveolar macrophages. 2-SA-dependent RNase L expression by alveolar macrophages. Previous studies have indicated that IL-1O can decrease cytokine levels through induction of an undefined endoribonuclease that degrades cytokine mRNA transcripts (31, 32) . TNF-a (or IFN) in concert with viral intermediates serve as the necessary signals to stimulate the expression and activation of the 2-5A-dependent RNase L (8). This endoribonuclease degrades single-stranded RNA with preference for UU and UA sequences and could potentially account for the decreased cytokine transcripts observed in RSV-infected alveolar macrophages. Expression of 2-5A-dependent RNase L by alveolar macrophages were examined by Western blots after exposure of these cells to medium alone (uninfected control, C), RSV (R), LPS (L), and RSV + LPS (R + L) (same doses as used above) (Fig. 4) . Cells exposed to medium or LPS (C and L, respectively) exhibited nearly undetectable levels of 2-SAdependent RNase L, while RSV and RSV + LPS potently Mol wt induced this enzyme (R and R + L, respectively). These results were reproduced in two separate experiments. Thus, RSV induces the expression of this, and perhaps other, endoribonucleases that may function to regulate the accumulation of cytokine mRNA transcripts critical to an effective immune response.
Discussion
RSV is the major pathogen of infant's lungs that causes damage by pathogenic mechanisms only partially understood (1) . RSV infects and replicates rapidly in respiratory airway epithelial cells as well as alveolar macrophages (21, 22) . A short replication cycle may allow the virus to elude cell-mediated and/or humoral responses regulated, in part, by macrophage function (5, 33, 34) . It has been shown that RSV directly alters alveolar macrophage expression of cytokines and major histocompatibility molecules (6, 7, 9, 10, 21 (8) (Fig. 4) . The 2-5A-dependent RNase L is induced and activated by two requisite signals, i.e., induction of the protein itself by IFN and production of the activator 2-5A by the TNF/IFN-induced 2-5A synthetase and double-stranded RNA (8, 37, 38) . The 2-5A-activated RNase L then functions as a potent antiviral enzyme degrading viral and cellular RNA (8 and references therein). The 2-5A-dependent RNase L may have a role in restricting RSV replication in human alveolar macrophages based on the following findings. Alveolar macrophages support efficient RSV replication for 24-72 h which thereafter declines by > 50-fold (23) . RSV-infected alveolar macrophages produce low levels of TNF-a as shown here and previously (9, 10), but addition of exogenous TNF-a markedly restricts RSV replication in these cells (21) . Furthermore, RSV does not induce type I IFN production as do other respiratory viruses (12, 39) . RSV and, less potently, RSV + LPS stimulated alveolar macrophages to increase expression of 2-SA-dependent RNase L (Fig. 4) whereas LPS alone was not stimulatory. However, LPS did induce high levels of TNF-a, a cytokine previously shown to induce 2-5A synthetase yielding 2-5A which then activates the 2-5A-dependent RNase L (37, 38) . It is possible that LPS induction of TNF-a serves to stimulate 2-SA synthetase while RSV induces 2-5A dependent RNase L. Thus cells costimulated with RSV + LPS could have higher levels of the activated 2-5A-dependent RNase L. The activated 2-SA-dependent RNase L may degrade viral and cytokine mRNA. The Northern blot results and transcript levels shown in Figs. 2 and 3 are consistent with this hypothesis. However, the level of induction of 2-5A-dependent RNase L may be inadequate to yield detectable degradation of abundant RNA species such as 18S ribosomal RNA levels, HPRT, or GAPDH transcripts (constitutively expressed), at least through 24 h. Because alveolar macrophages do not proliferate, direct examination of the role of 2-5A-dependent RNase L in restricting RSV replication or degradation of cytokine transcripts using strategies such as dominant negative mutants of 2-5A-dependent RNase L (40) are not yet possible.
The role of IL-10 in viral infections is only partially understood. IL-10 is expressed by Epstein-Barr-transformed lymphocytes and may have a proximal role in establishing the latent infection characteristic of this virus (17) . Vaccinia virus engineered to express IL-10 yields a selective stimulation of cytotoxic T lymphocytes and natural killer cells that could potentially facilitate latent viral infection (41) . IL-10 is expressed by lymph node cells in murine models after experimental infection with influenza (42) . Recently, murine studies suggest that a formalin-inactivated RSV vaccine primes production of IL-1O and IL-4 after RSV infection which yields enhanced pulmonary histopathology (43) . Here, we demonstrated in human cells that RSV potently enhanced IL-1O production which functioned biologically to inhibit the expression of critical immunoregulatory cytokines.
These results confirm previous studies of TNF-a and IL-1,8 expression by alveolar macrophages infected with RSV in vitro or in vivo (6, 7, 9, 10) but contrast with a prior study indicating that RSV increased alveolar macrophage production of IL-8 protein (10) . That study found that RSV-exposed alveolar macrophages accumulate low levels of IL-8 in supernatants (> 100 ng/ 106 cells), levels far less than the constitutive levels reported here and by other authors (25, 26) and far less than levels found in alveolar macrophages after simple adherence to plastic (29) . In addition, the RSV A2 strain used in those studies was propagated in HEp 2 cells, whereas we used RSV A2 strain (R. Chanock, National Institutes of Health, Bethesda, MD) that was plaque-purified and propagated in CV-1 cells, perhaps yielding virus stocks differing in biologic function. However, we did find that RSV yielded a slight increase in IL-8 mRNA transcripts (Fig. 2) , consistent with that prior study (10) , without yielding an increase in secreted IL-8.
Phagocytosis of pathogens, as well as production of immunoregulatory cytokines, serve as critical macrophage functions in their sentinel role of protecting the host against invading pathogens (33, 34) . Viruses have evolved mechanisms to subvert these macrophage defenses. RSV avoids phagocytic mechanisms by spreading from cell to cell after fusion and syncytial formation (1) . In addition, RSV does not stimulate a sustained expression of the antiviral cytokines TNF-a and IFN that could restrict viral replication (9, 12, 39) . Furthermore, although RSV induces expression of immunoregulatory cytokines, it simultaneously stimulates production of an IL-I inhibitor (44) . Here, we found that RSV directly stimulated IL-10 expression and secretion by alveolar macrophages which functioned to suppress early cytokine production by activated macrophages. These findings suggest that IL-1O may have a critical pathogenic role in the incomplete immune response to RSV.
